A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer

Clinical trial NCT07111832 · RECRUITING

Trial details

NCT number: NCT07111832
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer

Start date: 2025-08-20
Primary completion: 2028-03-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.